ATE247965T1 - Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung - Google Patents

Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung

Info

Publication number
ATE247965T1
ATE247965T1 AT00949569T AT00949569T ATE247965T1 AT E247965 T1 ATE247965 T1 AT E247965T1 AT 00949569 T AT00949569 T AT 00949569T AT 00949569 T AT00949569 T AT 00949569T AT E247965 T1 ATE247965 T1 AT E247965T1
Authority
AT
Austria
Prior art keywords
buspirone
pharmaceutical composition
composition containing
analgesic effect
containing paracetamol
Prior art date
Application number
AT00949569T
Other languages
English (en)
Inventor
Francoise Camborde
Alix Cloarec
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Application granted granted Critical
Publication of ATE247965T1 publication Critical patent/ATE247965T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00949569T 1999-06-30 2000-06-29 Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung ATE247965T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908363A FR2795645B1 (fr) 1999-06-30 1999-06-30 Nouvelle association pharmaceutique a activite analgesique
PCT/FR2000/001817 WO2001001989A1 (fr) 1999-06-30 2000-06-29 Nouvelle association pharmaceutique a activite analgesique contenant du paracetamol et de la buspirone

Publications (1)

Publication Number Publication Date
ATE247965T1 true ATE247965T1 (de) 2003-09-15

Family

ID=9547486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949569T ATE247965T1 (de) 1999-06-30 2000-06-29 Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung

Country Status (14)

Country Link
US (1) US6511982B2 (de)
EP (1) EP1189617B1 (de)
JP (1) JP2003503459A (de)
AT (1) ATE247965T1 (de)
AU (1) AU780341B2 (de)
CA (1) CA2373877A1 (de)
DE (1) DE60004833T2 (de)
EC (1) ECSP013869A (de)
ES (1) ES2204663T3 (de)
FR (1) FR2795645B1 (de)
HK (1) HK1046847B (de)
MX (1) MXPA01013403A (de)
TW (1) TW577741B (de)
WO (1) WO2001001989A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
CA2619768A1 (en) * 2005-08-19 2007-02-22 The Regents Of The University Of California Use of seh inhibitors as analgesics
US20070254960A1 (en) * 2006-04-28 2007-11-01 Gruenenthal Gmbh Pharmaceutical combination
US20120148547A1 (en) * 2009-09-01 2012-06-14 Hadasit Medical Reasearch Services & Development Ltd. Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
HRP20220112T1 (hr) 2013-12-24 2022-04-15 Virginia Commonwealth University Upotreba oksidacijskog sulfata kolesterola (ocs) za liječenje akutne insuficijencije jetre
US10813894B2 (en) 2015-02-20 2020-10-27 The Regents Of The University Of California Methods of inhibiting pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182763A (en) 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
IN158970B (de) * 1981-06-09 1987-02-28 Ici Plc
EP0093521B1 (de) * 1982-05-04 1988-08-24 Imperial Chemical Industries Plc Chinolinderivate
US4794112A (en) 1982-12-09 1988-12-27 Cooper Stephen A Acetaminophen/hydroxyzine analgesic combinations
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
GB2222768B (en) 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5872145A (en) 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物

Also Published As

Publication number Publication date
DE60004833D1 (de) 2003-10-02
EP1189617B1 (de) 2003-08-27
HK1046847A1 (en) 2003-01-30
ECSP013869A (es) 2002-09-27
US20010016584A1 (en) 2001-08-23
DE60004833T2 (de) 2004-08-12
FR2795645B1 (fr) 2001-09-21
EP1189617A1 (de) 2002-03-27
JP2003503459A (ja) 2003-01-28
MXPA01013403A (es) 2002-12-05
AU6288500A (en) 2001-01-22
FR2795645A1 (fr) 2001-01-05
HK1046847B (zh) 2004-11-26
TW577741B (en) 2004-03-01
ES2204663T3 (es) 2004-05-01
AU780341B2 (en) 2005-03-17
CA2373877A1 (fr) 2001-01-11
US6511982B2 (en) 2003-01-28
WO2001001989A1 (fr) 2001-01-11

Similar Documents

Publication Publication Date Title
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
ATE216879T1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
BR0311443A (pt) Método e dispositivo para controlar farmacocinética de droga
MY119403A (en) Novel compounds with analgesic effect.
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
NZ511201A (en) Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
DE60322436D1 (de) Verabreichung von capsaicinoiden
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
ATE301994T1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
DE60010456D1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
SE9802208D0 (sv) Novel compounds
DK1140198T3 (da) Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
ITTO981046A0 (it) Corredo di siringa ed aghi coordinati, per iniezioni, specialmente per anestesia odontoiatrica.
BR0108728A (pt) Combinação farmacêutica terapêutica, e, método para tratar um c ncer.
BR9508671A (pt) Método de alívio da dor e composição terapêutica
ATE247965T1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
SE9802209D0 (sv) Novel compounds
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
DK1537132T3 (da) Salt af mortin-6-glucuronid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1189617

Country of ref document: EP

REN Ceased due to non-payment of the annual fee